Accessibility Menu
Imac logo

Imac(OTC) BACK

Current Price$0.00
Market Cap$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-100%
5 Year-100%
1 Year-100%
1 Month-100%
Imac last closing stock price
MetricPriceDate
Last closeUSD 0.002026-07-24
Imac stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-98.92%USD 0.022026-07-17
1 month-99.58%USD 0.052026-06-24
3 month-99.61%USD 0.052026-04-24
Year to date-99.86%USD 0.142025-12-31
1 year-99.67%USD 0.062025-07-24
3 year-99.99%USD 3.282023-07-25
5 year-100%USD 45.302021-07-23
Since inception-100%USD 110.402019-02-13

Imac Financials at a Glance

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$22.72K

Net Income (TTM)

-$9.70M

EPS (TTM)

-$6.22

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.97 (Low)

Price

$0.00

Volume

6,398

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.21

Estimated Earnings Date

Aug 17, 2026

BACK News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Imac

IMAC Holdings, Inc. operates a network of advanced medical and regenerative care centers across the United States. The company specializes in innovative regenerative, orthopedic, and minimally invasive therapies aimed at treating various conditions, including athletic injuries and chronic pain.

Products and Services
  • Outpatient clinics offering regenerative and orthopedic therapies
  • Physical therapy and chiropractic manipulation services
  • Minimally invasive treatments for soft tissue ailments
Growth Outlook
  • Expansion of clinic locations across multiple states enhances market reach
  • Increasing demand for non-invasive treatment options supports growth potential
  • Focus on innovative therapies positions the company for future advancements
Financial Highlights
  • Recent quarterly revenue of $21,223 reflects ongoing operational challenges
  • Trailing twelve months show a net income loss of $3,078,533
  • Current assets totaled $310,055, indicating liquidity concerns
IMAC Holdings, Inc. is positioned within the healthcare sector, specifically in medical care facilities. The company has established a presence in several states, including Kentucky, Missouri, Tennessee, Illinois, Louisiana, and Florida, with a total of 15 outpatient medical facilities. Despite facing financial challenges, including significant net income losses, the company continues to focus on expanding its services and improving patient care through innovative therapies. The growth outlook remains promising, driven by increasing demand for non-invasive treatment options and the potential for further clinic expansions. Investors may find interest in the company's strategic positioning within the evolving healthcare landscape.
AI Generated • Jul 24, 2026

Industry

Biotechnology

Employees

15

CEO

Faith Zaslavsky

Headquarters

Franklin, TN 37027, US

BACK Financials

Key Financial Metrics (TTM)

Gross Margin

-1349.60%

Operating Margin

-26468.83%

Net Income Margin

-32560.25%

Return on Equity

72.93%

Return on Capital

N/A

Return on Assets

-2386.24%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

-2.93%

Stock Overview

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

3.79M

Volume

6.40K

Avg. Volume

11.44K

Financials (TTM)

Gross Profit

-$417.84K

Operating Income

-$7.83M

EBITDA

-$8.37M

Operating Cash Flow

-$4.89M

Capital Expenditure

$2.00

Free Cash Flow

-$4.89M

Cash & ST Invst.

$45.05K

Total Debt

$3.83M

Imac Performance Analysis

Imac annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 14,385,828N/A
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 72,050N/A
Imac sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-100.0%
Q12025-03-31N/A
Q22025-06-30-100.0%
Q32025-09-30N/A
Imac annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -14.02N/A
20222022-12-31USD -458.193167.2%
20232023-12-31USD -7.48-98.4%
20242024-12-31USD -7.702.9%
Imac sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-31-106.4%
Q12025-03-3156.5%
Q22025-06-3036.4%
Q32025-09-30-29.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$21.22K

-62.3%

Gross Profit

-$102.65K

-56.1%

Gross Margin

-4.84%

N/A

Market Cap

$800.00Market cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$53.33

N/A

Employees

15

N/A

Net Income

-$3.08M

-39.6%

EBITDA

-$2.55M

-31.2%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Total Cash

$45.05K

-77.0%

Total Debt

$3.83M

+151.7%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$3.83M

+151.7%

Return on Assets

-23.86%

N/A

Return on Invested Capital

46.35%

N/A

Free Cash Flow

-$1.42M

-29.9%

Operating Cash Flow

-$1.42M

-29.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BCTXWBriaCell Therapeutics Corp.
$0.00-0.00%
CEROCERo Therapeutics Holdings, Inc.
$0.01-5.66%
PPBTPurple Biotech Ltd.
$1.43+2.88%
NUWENuwellis, Inc.
$2.05-6.82%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About BACK

What is the current price of Imac?

Imac is trading at $0.00 per share.

What is the 52-week range for Imac?

Over the past 52 weeks, Imac has traded between $0.00 and $0.21.

How much debt does Imac have?

As of the most recent reporting period, Imac reported total debt of $3.83M.

How much cash does Imac have on hand?

Imac reported $45.05K in cash and cash equivalents in its most recent financial results.

What is Imac’s dividend yield?

Imac does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.